Cusato, J.; Ribaldone, D.G.; Falzone, M.H.; Manca, A.; Antonucci, M.; Palermiti, A.; Saracco, G.M.; Ceccarelli, L.; Costa, F.; Bottari, A.;
et al. Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study. Biomedicines 2024, 12, 824.
https://doi.org/10.3390/biomedicines12040824
AMA Style
Cusato J, Ribaldone DG, Falzone MH, Manca A, Antonucci M, Palermiti A, Saracco GM, Ceccarelli L, Costa F, Bottari A,
et al. Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study. Biomedicines. 2024; 12(4):824.
https://doi.org/10.3390/biomedicines12040824
Chicago/Turabian Style
Cusato, Jessica, Davide Giuseppe Ribaldone, Michela Helga Falzone, Alessandra Manca, Miriam Antonucci, Alice Palermiti, Giorgio Maria Saracco, Linda Ceccarelli, Francesco Costa, Andrea Bottari,
and et al. 2024. "Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study" Biomedicines 12, no. 4: 824.
https://doi.org/10.3390/biomedicines12040824
APA Style
Cusato, J., Ribaldone, D. G., Falzone, M. H., Manca, A., Antonucci, M., Palermiti, A., Saracco, G. M., Ceccarelli, L., Costa, F., Bottari, A., Fornaroli, G., Caviglia, G. P., D’Avolio, A., & Bertani, L.
(2024). Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study. Biomedicines, 12(4), 824.
https://doi.org/10.3390/biomedicines12040824
